Perspective Therapeutics Files 8-K

Ticker: CATX · Form: 8-K · Filed: Dec 4, 2024 · CIK: 728387

Sentiment: neutral

Topics: 8-K, company-name-change, disclosure

TL;DR

Perspective Therapeutics filed an 8-K on Dec 4th for a Dec 3rd event. Details TBD.

AI Summary

Perspective Therapeutics, Inc. (formerly Isoray, Inc.) filed an 8-K on December 4, 2024, reporting an event on December 3, 2024. The filing indicates a change in the company's status or operations, though specific details of the event are not provided in this excerpt. The company, incorporated in Delaware, is located in Seattle, Washington.

Why It Matters

This filing signals a material event for Perspective Therapeutics, Inc., requiring disclosure to investors and the public.

Risk Assessment

Risk Level: medium — An 8-K filing indicates a significant event, but the lack of specific details in this excerpt necessitates a medium risk assessment until more information is available.

Key Numbers

Key Players & Entities

FAQ

What specific event occurred on December 3, 2024, that necessitated this 8-K filing?

The provided excerpt does not specify the nature of the event reported on December 3, 2024.

What was Perspective Therapeutics, Inc. previously known as?

Perspective Therapeutics, Inc. was formerly known as Isoray, Inc. and IsoRay, Inc.

In which state is Perspective Therapeutics, Inc. incorporated?

Perspective Therapeutics, Inc. is incorporated in Delaware.

What is the principal business address of Perspective Therapeutics, Inc.?

The principal business address is 2401 Elliott Avenue, Suite 320, Seattle, Washington 98121.

What is the SIC code for Perspective Therapeutics, Inc.?

The Standard Industrial Classification (SIC) code is 3841, for SURGICAL & MEDICAL INSTRUMENTS & APPARATUS.

Filing Stats: 417 words · 2 min read · ~1 pages · Grade level 10.5 · Accepted 2024-12-03 21:31:57

Key Financial Figures

Filing Documents

01 Other Events

Item 8.01 Other Events. On December 3, 2024, Perspective Therapeutics, Inc. posted an updated corporate presentation on its website at www.perspectivetherapeutics.com. A copy of the presentation is filed as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference into this Item 8.01.

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Corporate Presentation . 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. PERSPECTIVE THERAPEUTICS, INC. Date: December 3, 2024 By: /s/ Johan (Thijs) Spoor Johan (Thijs) Spoor, Chief Executive Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing